Check-Cap Ltd. (CHEK)
NASDAQ: CHEK · Real-Time Price · USD
2.390
+0.140 (6.22%)
At close: Oct 2, 2025, 4:00 PM EDT
2.360
-0.030 (-1.26%)
After-hours: Oct 2, 2025, 6:07 PM EDT
Check-Cap Employees
Check-Cap had 85 employees as of December 31, 2022. The number of employees increased by 4 or 4.94% compared to the previous year.
Employees
85
Change (1Y)
4
Growth (1Y)
4.94%
Revenue / Employee
n/a
Profits / Employee
-$295,871
Market Cap
13.98M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 85 | 4 | 4.94% |
| Dec 31, 2021 | 81 | 16 | 24.62% |
| Dec 31, 2020 | 65 | 1 | 1.56% |
| Dec 31, 2019 | 64 | 8 | 14.29% |
| Dec 31, 2018 | 56 | 8 | 16.67% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CHEK News
- 5 months ago - Apollo Technology Capital Corporation Poses Questions That MediPharm Shareholders Should Ask on Management's Conference Call with Shareholders - PRNewsWire
- 5 months ago - MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders - PRNewsWire
- 5 months ago - Apollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value Destruction - PRNewsWire
- 1 year ago - Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement - PRNewsWire
- 1 year ago - SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD - PRNewsWire
- 1 year ago - CHECK- CAP BOARD MEMBER'S STATEMENT ON THE STAND SUGGESTS A POTENTIAL CONFLICT OF INTEREST WITH KEYSTONE DENTAL - PRNewsWire
- 1 year ago - CITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEES - PRNewsWire
- 1 year ago - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEES - PRNewsWire